Trial intelligence / Profile preview

Comparison of surfactant with and without budesonide in neonatal respiratory distress syndrome

IRCT20211218053444N3Phase 3Completed

Sponsor
Kerman University of Medical Sciences
Start
Dec 2023
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of budesonide in respiratory distress syndrome (RDS) (2 arms), sponsored by Kerman University of Medical Sciences. Started Dec 2023; status: completed.

02

Drugs

budesonide
03

Conditions

respiratory distress syndrome (RDS)

Beyond the preview

Go deeper on IRCT20211218053444N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20211218053444N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call